Floatz logo

SULFAMETHOXAZOLE

Leukemia

Monash UniversitySmall moleculePhase 2/3Active
CCC
50/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
65/ 100

Competitive context

124 Active assets in the Leukemia cohort.

Asset / SponsorPhaseRating
VINCRISTINE SULFATE
Inhye Ahn
Phase 3BB
MERCAPTOPURINE ANHYDROUS
Dana-Farber Cancer Institute
Phase 3BB
ASPARAGINASE
Gruppo Italiano Malattie EMatologiche dell'Adulto
Phase 3BB
Idarubicine
Affiliated Hospital of Nantong University
Phase 3BB
FILGRASTIM
Hospital General de Mexico
Phase 4BB

View all 50 →

Same molecule, other indications

SULFAMETHOXAZOLE is also rated in:

infectious diseaseDormant
A
Indicative ·
81 / 100
View asset →
methicillin-resistant staphylococcus aureus infectious diseaseDormant
BBB
Indicative ·
75 / 100
View asset →
MyelomaDormant
BB
Indicative ·
71 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →